LATEST ALERTS
With the federal legalisation of hemp in the US , states were left to enact their own legislation to adapt. CBD-Intel provides an overview of US law on smokable hemp, along with analysis of each state’s rules
This week’s regulatory news in brief brings updates from the EU, Germany, Iceland, Lithuania Poland, Canada Mexico, the US, Brazil, Lebanon and South Korea
Cultivation of cannabis and manufacture of cannabis-derived products is permitted in Colombia under a licence. This report provides all current regulatory information in place in the country
As the coronavirus pandemic continues, regardless of location, there is an overwhelming sense of uncertainty in the CBD industry. In this special episode, Tim Phillips – the founder and managing director of CBD-Intel — provides some analysis relating to the three main areas impacted in CBD industry: demand, supply, and regulation; however, he believes that it is too early to discuss the long-term impacts.
A new national committee is to be set up in Canada to study all aspects of non-prescription cannabis health products, including CBD products
Further advances towards the legalisation of cannabis in Mexico have been delayed by a government shutdown due to the COVID-19 pandemic, with a new deadline for legislation set by the country’s Supreme Court
Cultivation and processing of hemp is currently not allowed in Mexico, however there have been recent proposals for legalisation. This report provides an overview of the current regulatory landscape, as well as likely future regulation
Companies that have made claims about CBD’s beneficial effects against COVID-19 are facing swift enforcement action from US regulatory authorities
This week’s regulatory news in brief brings updates from the EU, Albania, France, Italy, the Netherlands, Spain, the US, Australia, New Zealand and Panama
The government of Uzbekistan has allowed the turnover and imports of hemp and its related products within its territory, according to recent statements made by the press service of the Uzbek Presidential Administration
Pure CBD is not itself regulated under the Croatian drug regime. This report provides a detailed overview of the current regulatory framework, including finished products, extracts, medical and recreational cannabis
The US Drug Enforcement Administration (DEA) has removed Epidiolex, the only CBD drug so far approved by the US Food and Drug Administration (FDA), from its list of controlled substances
CBD entrepreneur Christina DiArcangelo tells CBD-Intel that businesses should be using the slowdown to study, reflect, plan – and “get ahead of the ball”
The wider impact of COVID-19 on the CBD sector in the US remains confused in the short term and largely a mystery in the longer term as companies scramble to gather information
This week’s regulatory news in brief brings updates from the EU, Belgium, Germany, Lithuania Switzerland, Slovakia, Canada, Mexico, the US, Israel, Lebanon, Peru and New Zealand
This week’s regulatory news in brief brings updates from the EU, Italy, Canada, Mexico, the US, Australia, China, Colombia, Israel, New Zealand and Uzbekistan.
Four months after Zambia legalised the production and export of cannabis, no one has yet been able to take advantage because of the high cost of licensing fees – and some confusion remains about what is allowed
Legislative measures are on hold in half the states of the US due to the COVID-19 emergency, with most suspending activity until at least mid-April
This week’s regulatory news in brief brings updates from Belgium, the EU, North Macedonia, Canada, the US, Australia, Bolivia, Colombia, Ghana, Panama, Peru and Thailand
Also: £500k funding for online retailer; Hollister picks magic mushroom researchers; KushCo scales back trading prediction; HempNova prepares to grow and process in Oregon
The head of the US Department of Agriculture (USDA) has blamed the Drug Enforcement Agency (DEA) for heavily criticised measures in the recently proposed federal hemp production rules
FDA commissioner Stephen Hahn has told a Congressional subcommittee that more research and data are needed before the FDA is ready to issue a formal policy on CBD products
This presentation provides an overview of the CBD consumer segmentation, including the current user profile and the reasons for use. This analysis is the perfect aid for understanding customer characteristics, and it offers insights for recognising usage frequency which may vary between medicinal and wellness purposes. CBD-Intel managing director Tim Phillips gave this informative presentation […]
Expected retail closures will have a significant impact on the distribution of CBD products in most major markets, according to analysis of CBD-Intel data
Bogus claims that products containing CBD may have any beneficial effects in treating or warding off coronavirus risk the wrath of authorities in the US – and could ultimately damage CBD’s reputation
This week’s regulatory news in brief brings updates from Austria, Germany, Netherlands,UK, Canada, Mexico, the US, Australia, Israel and Myanmar
Lenka Hajnovicova, one of CBD-Intel’s legal analysts, presented the latest challenges and trends in light of the current regulatory framework of the cannabidiol sector at the Canapa Mundi in Rome on 23rd February. She discussed the key pitfalls of the regulation of CBD and CBD products in Europe and their impact on the market, as […]
Our managing director, Tim Phillips, recently discussed global CBD opportunities during the USA CBD Expo in Las Vegas in February. He explored medical and recreational cannabis and their developments, CBD as an ingredient in health and wellness, the market share in grey markets, and regulatory changes in food and cosmetics. Tim also focused on the […]
Unclear testing standards for CBD oil in the UK have led to uncertainty over test results on THC and CBD content for many popular CBD products
The legal framework and licencing regime are not fully in place yet in Thailand, and the overall regulations – which affect sales, imports, exports and possession of hemp and cannabis extracts – are restrictive
This week’s regulatory news in brief brings updates from the EU, Finland, Germany, Italy, the Netherlands, Switzerland, Mexico, the US, Colombia, Israel, Lebanon, Myanmar and Paraguay
The United Nations’ central drug policy agency has declined to reveal why it again postponed a vote on WHO recommendations to relax restrictions on cannabis and related substances such as CBD and THC
The Food and Drug Administration (FDA) has released an update on CBD enforcement to members of Congress
Companies are beginning to show interest in Kazakhstan ahead of an anticipated liberalisation of cannabis laws they hope will allow the cultivation and production of hemp products for medical, food and other purposes
Other stories here: Frustrated wine-grower turns to hemp research; Patent given for CBD/CBG ‘micropearl’; GW reclaims UK rights to Sativex; Kentucky crop to be destroyed; Fight goes on over rights to cream formula
One of the 12 US regional reserve banks has complained about the banking industry’s reluctance to service hemp and CBD businesses even though they are now legal products
Legislative efforts will continue to push for cannabinoid liberalisation in the Philippines – despite recent comments that approval in principle of the epilepsy drug Epidiolex would be sufficient to cover most matters
This regulatory report covers the current situation for CBD in Belgium, looking at finished products, extracts, import and export rules and more
This week’s regulatory news in brief brings updates from the US, Colombia, Germany, Slovenia and Luxembourg
German authorities and a major European hemp association have disagreed on the implications of correspondence regarding the novel status of hemp extracts
A coalition of organisations linked to the US hemp market has released the first part of a series of policy recommendations – while one CBD firm has been referred to the US Federal Trade Commission over extravagant health claims
A bill legalising hemp and medical cannabis has been passed in Malawi, making it the fifth African country to pass some form of cannabis legalisation
Malaysia has a tough regime on hemp products. Cultivation is prohibited because hemp falls into the cannabis legal framework. The previous government had started to look into the possibility of legalising hemp cultivation and processing
This week’s regulatory news in brief brings updates from the EU, Mexico, the US, Lebanon, Malawi, Peru and the Philippines
CBD products will not be banned in the US and there is some medicinal value to them being on the market, US Food and Drug Administration (FDA) commissioner Stephen Hahn has said
The US Department of Agriculture (USDA) is to temporarily delay enforcement of two controversial provisions in its interim hemp production rule after receiving a large quantity of critical feedback
The Hemp Federation of Ireland (HFI) has taken issue with a report from the Food Standards Agency of Ireland (FSAI) and the order to remove a number of specified CBD products from shelves
Testing in the field could counter a major stated reason for enacting bans on smokable hemp in the US, but a perfect technical solution has not yet been found
Two bills in the US House of Representatives, relating to banking and medical cannabis research, appear to be dead, with not enough time to pass the measures in 2020 despite wide support
Several US hemp farmers have spoken to CBD-Intel expressing concern over the crop-testing provisions set out in the US Department of Agriculture (USDA)’s interim final rule on hemp production
Stay up-to-date with key regulatory news and receive complimentary data on a regular basis.
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields
